Scientists have identified a new protein (C5orf30) which regulates the severity of tissue damage caused by rheumatoid arthritis (RA), an autoimmune disease that causes inflammation, pain, stiffness and damage to the joints of the feet, hips, knees, and hands. To conduct the research, the international team of scientists from UCD School of Medicine and the University of Sheffield, funded by Arthritis Ireland and the University of Sheffield, analysed DNA samples and biopsy samples from joints of over 1,000 Rheumatoid arthritis patients in the United Kingdom and Ireland.
Researchers in the biomedical proteomics group in UCD hosted an All-Ireland Cooperative Oncology Research Group (ICORG) patient open event with colleagues in St Luke's Institute of Cancer Research on Friday, 28 August 2015. Prostate cancer patients who support the research efforts of clinicians at St Luke’s Hospital, Rathgar and scientists in UCD Conway Institute had an opportunity to take a look at the research laboratories and hear first-hand of the progress so far in research projects.
World renowned experts in the field of diabetes met in UCD Conway Institute on 24th August, is association with Irish Society for Clinical Nutrition and Metabolism, to discuss radical new interventions in the treatment of diabetes. The Conference entitled ‘Reversing end organ damage through diabetes surgery’ was chaired by UCD Professor, Carel la Roux and highlighted the possibility of a newly defined discipline, diabetes surgery, being used more widely to treat the most severe of diabetes cases.
Drug companies are taking a systematic approach to getting maximum use out of old drugs, a development that is “welcome and necessary in many clinical areas”, according to the Health Products Regulatory Authority. Prof Patrick Murray, Dean, School of Medicine and Prof of Clinical Pharmacology, UCD, was recently asked to contribute to an Irish Times feature on this issue.